Production of Remdesivir to be ramped up: Govt

According to the national treatment protocol, remdesivir is one of the investigational drugs approved for use in treating hospitalised Covid-19 patients. With the rising cases, the demand for the drug has also shot up.

The Centre on Wednesday approved ramping up the production of antiviral drug remdesivir amid a sudden surge in Covid-19 cases across the country.

Union minister of state for chemicals and fertilizer Mansukh Mandaviya reviewed the availability of the drug in the country with all existing manufacturers at several meetings held on Monday and Tuesday (AFP)

According to the national treatment protocol, remdesivir is one of the investigational drugs approved for use in treating hospitalised Covid-19 patients. With the rising cases, the demand for the drug has also shot up.

“The current total installed capacity of the seven manufacturers of Remdesivir is 38.80 lakh vials per month. Fast-track approval has been given for seven additional sites having the production capacity of 10 Lakh vials /month to six manufacturers. Another 30 lakh vials/month production is lined up. This would ramp up the production capacity for manufacturing to around 78 lakh vials/month,” said Union ministry of chemicals and fertilisers in a statement issued on Wednesday.

Union minister of state for chemicals and fertilizer Mansukh Mandaviya reviewed the availability of the drug in the country with all existing manufacturers at several meetings held on Monday and Tuesday